All Insights

Decarbonisation

UK looks to deliver natural gas and hydrogen projects for freight transport 

Non-electric transport fuels are attractive alternative power sources that need infrastructure, finance and regulation
Financial Services

Investment funds and asset management: the international road ahead for 2023

What UK, EU and international legislative and non-legislative developments can be expected over the next 12 months?
Knowledge Notes

UK business law predictions for 2023

As the new year unfolds, we look ahead at what legal developments businesses can expect
ESG, sustainability and responsible business

FCA announces plan to develop a code of conduct for ESG data and ratings providers in UK

Regulator's growing focus on ESG continues with concerns over the subjective nature of sustainability data and greenwashing risk
Financial Services

Confirmation of payee: a valuable international tool in the fight against fraud?

UK and Netherlands adoption will help combat payment fraud domestically but a lack of international uptake is worrying
The Built Environment

A look ahead for UK real estate in 2023

The new year will be a busy one – including the implementation of new regimes for overseas ownership of UK
Life Sciences and Healthcare

New year brings healthcare professional interaction rule update in Belgium

The new rules offer more flexibility to life sciences businesses interacting with health professionals and organisations
Financial Services

EU financial services firms face tougher cybersecurity rules in two years

The European authorities have adopted rules on digital operational resilience to tackle risks and harmonise requirements
Financial Services

FTX – another warning shot for crypto audits?

The recent collapse of crypto-exchange FTX highlights the risks associated with auditing crypto-currency businesses
Employment and pensions

UK Pensions Regulator consults on new defined benefit funding code

The draft code, fast-track parameters and proposed regulatory approach have been released for industry feedback
Life Sciences and Healthcare

Products without an intended medical purpose: EU clarifies conditions

Non-medical product manufacturers have limited time to prepare for new risk management and clinical data obligations
Retail and Consumer

Poland's Office of Competition and Consumer Protection investigates 'dark patterns'

Entrepreneurs can be fined up to 10% of their turnover for violating the collective interests of consumers